Low‑dose trametinib and Bcl‑xL antagonist have a specific antitumor effect in KRAS‑mutated colorectal cancer cells.
Koyama M, Kitazawa M, Nakamura S, Matsumura T, Miyazaki S, Miyagawa Y, Muranaka F, Tokumaru S, Okumura M, Yamamoto Y, Ehara T, Hondo N, Takahata S, Takeoka M, Miyagawa SI, Soejima Y.
Koyama M, et al. Among authors: nakamura s.
Int J Oncol. 2020 Nov;57(5):1179-1191. doi: 10.3892/ijo.2020.5117. Epub 2020 Sep 2.
Int J Oncol. 2020.
PMID: 32901840